NLS Financing

The board of directors of Senzime has resolved on a directed share issue of a maximum of 13 873 000 shares at the subscription price of SEK 6.20 per share.

Vicore Pharma Holding has announced an investment from Sanofi in Vicore through a commitment to subscribe for shares in the ongoing rights issue corresponding to a total of approximately USD 10 million.

The company has recently raised SEK 10 million in directed issue for a novel obesity-related study. The aim is to study drug tolerance and the effects of the company’s molecule on obesity. The Phase-2a-study will be conducted over the next year and the capital raised will support the study with the objective to assess the […]

The Theranostics Trial Center (TTC) at Karolinska University Hospital has been awarded financing from Vinnova to run a new project in precision medicine. By combining image-guided diagnostics and therapy with radioactively labeled target-seeking drugs, the project aims to revolutionize cancer treatment in Sweden. “This grant is a big step for our research and a clear […]

AstraZeneca is making an additional investment of USD 135 million in its facility for biologics in Södertälje. “We are happy about this investment in Södertälje, which demonstrates AstraZeneca’s commitment to innovation and manufacturing of biological medicines in Sweden,” says Per Alfredsson, CEO of AstraZeneca AB and Senior Vice President for Global Biologics Operations. The investment […]

NADMED has closed a series A round to fund its entry into the U.S. and other international markets with its nicotinamide adenine dinucleotide (NAD) measurement technology that may help clinicians establish more precise and personalized treatments for various diseases. The round was led by Finnish science-based startup investor Nordic Science Investments (NSI). Additional funding was secured […]